Description
GLYSIT-MET 5/1000 mg Tablets – 30’s
GLYSIT-MET 5/1000 mg Tablets combine two complementary antidiabetic agents: Empagliflozin (5 mg), a selective SGLT2 inhibitor, and Metformin Hydrochloride (1000 mg), a biguanide class oral hypoglycemic. This fixed-dose combination is used in the treatment of type 2 diabetes mellitus, especially in patients who require dual therapy to achieve better glycemic control.
Empagliflozin works by reducing glucose reabsorption in the kidneys, promoting glucose excretion in urine. Metformin lowers hepatic glucose production and enhances insulin sensitivity. Together, they provide a comprehensive and synergistic effect on lowering blood glucose, with a low risk of hypoglycemia and added cardiovascular and renal protective benefits.
This 30-tablet pack offers a convenient once or twice-daily dosing regimen, depending on individual clinical needs.
Key Features:
-
Fixed-dose combination of Empagliflozin 5 mg + Metformin 1000 mg
-
Dual mechanism: reduces glucose production and enhances urinary excretion
-
Effective for both fasting and postprandial glucose control
-
Weight-neutral or may aid in weight loss
-
Provides cardiovascular and kidney protective benefits
-
Pack of 30 tablets for regular monthly therapy
Usage:
Take as prescribed by your healthcare provider, typically with meals to minimize gastrointestinal side effects. Regular blood sugar and kidney function monitoring is advised.
Reviews
There are no reviews yet.